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INTRODUCTION
Dystrophic epidermolysis bullosa (DEB) is caused by muta-
tions in the COL7A1 gene encoding collagen VII, the major
component of anchoring fibrils (1, 2). DEB is clinically char-
acterized by mucocutaneous blistering in response to minor
trauma, followed by scarring and nail dystrophy. It occurs as
either an autosomal dominant (DDEB) or recessive (RDEB)
trait, each form having unique clinical features and severity (3).
The most severe RDEB subtype, the Hallopeau-Simens
(HS) type, shows a complete lack of expression of type VII
collagen, whereas some collagen expression is found in the
non-Hallopeau-Siemens (non-HS) type (4, 5). The most severe
form, HS-RDEB, was usually caused by combinations of pre-
mature termination codon (PTC) mutations (6, 7). The non-
HS type with the presence of some type VII collagen expres-
sion is generally due to a combination of PTC with mis-sense
mutations including glycine substitution, in-frame deletion
or a splice site mutation (8). These glycine substitution muta-
tions cause various phenotypes. In the heterozygous state,
some glycine substitution mutations cause a dominant DEB
phenotype through a dominant negative interference or cause
limited nail dystrophy or no phenotype at all (9-11). How-
ever, glycine substitution mutations lead to a moderately
severe phenotype of RDEB when in the homozygous state or
when combined with a PTC in the other COL7A1 allele (12). 
In this study, we have systematically screened the COL7A1
gene, for mutational analysis in a RDEB Korean patient, 15-
yr-old male, showing multiple erosion, crusts, milia forma-
tion on scar, mitten-like deformity of hand, and dysphagia,
due to esophageal stricture, evidenced by esphagogram exam-
ination. 
MATERIALS AND METHODS
Patient
A 15-yr-old male patient visited, suffering from multiple
erosion, deformity of hand, and dysphagia. Several trauma-
induced erosions and blister had developed mainly on his
hands and trunk since infancy. His parents were non-con-
sanguineous, and his family members including his siblings
were clinically unaffected. 
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Type VII Collagen Gene Mutations (c.8569G>T and c.4879G>A) Result
in the Moderately Severe Phenotype of Recessive Dystrophic 
Epidermolysis Bullosa in a Korean Patient 
Dystrophic epidermolysis bullosa (DEB) are caused by mutations in the COL7A1
gene, which encodes type VII collagen. Even though more than 500 different COL7A1
mutations have been identified in DEB, it still remains to be under-investigated. To
investigate the mutation of COL7A1 in moderately severe phenotype of recessive
DEB (RDEB) in a Korean patient, the mutation detection strategy was consisted of
polymerase chain reaction (PCR) amplification of genomic DNA, followed by het-
eroduplex analysis, nucleotide sequencing of the PCR products demonstrating
altered mobility. In this study, we found that one mutation (c.8569G>T) was detect-
ed within exon 116. The mutation of c.8569G>T in exon 116 changed the GAG (Glu)
to TAG, eventually resulted in premature termination of type VII collagen polypep-
tide. Furthermore the mother did not have the mutation c.8569G>T in exon 116.
The other novel mutation (c.4879G>A) was detected within exon 51 of both patient
and mother, thereby resulting in changing valine (Val) to isoleucine (Ile) in type VII
collagen polypeptide. Taken together, in this study we identified compound heterozy-
gosity for COL7A1 mutations (c.8569G>T and c.4879G> A) in moderately severe
RDEB in a Korean patient. We hope that this data contribute to the expanding data-
base on COL7A1 mutations in DEB. 
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Primer design 
For amplification of segments of genomic DNA, the pri-
mers were designed on the basis of flanking intronic sequences
as previously reported by Christiano et al. (13). The oligomer
primers were 20 nucleotides in length, contained no greater
than three identical consecutive bases, minimal secondary
structure, between 45 and 65% G/C content, and were free
of the potential for primer-dimer formation. Amplimers ranged
from 196 to 589 bp in size. Primers were synthesized using
an automated oligonucleotide synthesizer (Bioneer Co., Dae-
jeon, Korea).
Polymerase chain reaction (PCR) amplification of genomic
DNA 
For PCR amplification of genomic sequences, DNA was
isolated from peripheral blood by the DNA extraction kit
(Qiagen Co., Valencia, CA, U.S.A.), according to the manu-
facturer’s recommendation. Purified DNA was used as a tem-
plate in a reaction volume of 50 μ L, containing 20 pM of
each primer, 100 nM MgCl2, 20 mM of each nucleotide, and
2.5 U Taq polymerase (Perkin-Elmer, Cetus, MO, U.S.A.).
The conditions for PCR were similar for each primer pair,
except that the annealing temperature varied. After denatu-
Fig. 1. Clinical features. Blisters and erosions were seen on the trunk (A, B) as well as milia (inset). Acral scaring and loss of finger and toe
nail (C, D). 
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ration for 5 min at 94℃, each PCR cycle consisted of 94℃,
45 sec; annealing 55-61℃, 45 sec; 72℃45 sec; for 40 cycles.
The PCR amplification products were examined on 2% aga-
rose gels. The PCR amplimers were examined for detection
of sequence variants by electrophoretic scanning techniques
such as the heterodulpex analyses described below.
Heterodulpex analyses
Heteroduplex analyses were performed using conformation-
sensitive gel electrophoresis (CSGE), as described by Gangu-
ly et al. (14). For CSGE, 8 μ L of each sample was denatured
by heating at 98℃ for 5 min, followed by cooling at 68℃
for 1 hr. Loading dye (2 μ L) was added and the samples were
run on the CSGE gel overnight at 300 V in 0.25×TBE buffer
(top chamber) and 1×TBE buffer (bottom chamber). Visu-
alization of bands was then performed in ethidium bromide
solution (1 ng/mL in 0.5×TBE). 
Mutation detection
If bands with altered mobility were detected, the PCR
products were sequenced. In some cases, the PCR products
were subcloned into the TA-cloning vector according to the
manufacturer’s recommendation (Invitrogen, San Diego, CA,
U.S.A.). Plasmid minipreparations were performed using
the standard boiling methods, and several positive clones
were sequenced by the dideoxynucleotide sequencing method
(15). Alternatively, the PCR products were purified on a chro-
matographic column (QIAquick Spin column, Qiagen, Valen-
cia, CA) and then subjected to direct dideoxynucleotide se-
quencing in an automated DNA sequencer (Applied Biosys-
tems, Foster, CA, U.S.A.) with the same primers used for
PCR amplification. The variant sequences in patients affect-
ed with DEB were compared with those in unaffected fami-
ly members. Comparative sequence analysis with the normal
COL7A1 template sequence, deposited in Gene Bank under
accession No. L23982, was also performed.
RESULTS
Clinical features
The patient showed the multiple erosion and crusts forma-
tion on trunk with scattered blister formation (Fig. 1A, B).
He also was suffered from dysphagia due to stricture of gas-
troesophageal junction, observed by esophagography. His
fingers and toes were shortened and contracted due to repeat-
ed blister formation, healing, and eventually scarring with
Fig. 2. The schematic presentation of the pedigree of the patient.
The black arrow indicates the patient.
Patient
Fig. 3. Histological findings. Subepidermal blister formation and flattened rete ridges are observed (A) (H&E, ×200). Electron micrograph
showing a few amount of anchoring fibrils (arrow heads) beneath the lamina densa (LD) (B). 
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mild fusion between webs (Fig. 1C, D). The pedigree showed
that there is no affected person’s among parents and relatives,
except the patient (Fig. 2).
Histologic examination 
An examination of the patient’s skin showed detachment
of epidermis from dermis by may be due to subepidermal
blister formation (Fig. 3A). According to electron micrograph
showed that markedly decreased anchoring fibril beneath the
lamina densa in patient, compared to normal (Fig. 3B)
Mutational analysis of COL7A1
Heteroduplex analyses using amplified DNA from RDEB
family revealed band shifts in the affected individual for PCR
products spanning, within exon 116. The homoduplex band
was seen in his mother. Unfortunately, we did not perform
heteroduplex analysis of DNA from his father, due to the
divorce state. Direct sequencing of the PCR products from
the patient revealed G to T transition at position 8569. As
a result, the codon for glutamic acid (GAG) is changed to a
codon for stop (TAG), and this mutation was designated
c.8569G>T and did not present in the maternal DNA sam-
ples. (Fig. 4A). Furthermore the mutation of c.8569G>T
was confirmed by restriction enzyme (XspI), specifically rec-
ognizes and digests in CTAG nucleotide sequence. A further
study revealed that G to A transition at position 4879 with-
in exon 51. As a result, the codon for valine (VAL) is changed
to a codon for isoleucine (Ile), and this mutation was detect-
ed both patient and mother DNA samples. Thus, our patient
has a premature termination codon (Glu →Stop, 2857) muta-
Patient mutation
G/T heteroduplex:
(p.E2857X)
c.8569G>T
(Restriction enzyme, TCCTAG)
NC-1 NC-2 Triple helical domain
Patient Mother
301 bp
Positive
control
Negative
control
Xsp I
A
C
387 bp
243 bp
144 bp
178 bp
128 bp
B D CC * CCC C CC
Fig. 4. Identification of the mutations in COL7A1 in patient. Direct sequencing of the patient PCR product revealed G to T transition at position
8569 (A). As a result, the codon for Glu (GAG) is changed to a codon for stop (TAG). This mutation was confirmed by restriction enzyme,
XspI (C). Schematic representation of the domain structure of procollagen VII and the location of the premature stop codon (E2857X) in
exon 116 (D). Cysteine residues are marked as a ‘‘C’’, and an asterisk ( * ) shows the procollagen C-proteinase cleavage site.
Fig. 5. Identification of the mutations in COL7A1 in the patient and mother. Direct sequencing of the patient PCR product revealed G to A
transition at position 4879 (A). As a result, the codon for Val (GUU) is changed to a codon for Ile (AUU). This mutation was confirmed by
restriction enzyme, Alw NI (B). 
A B
c.4879G>A, Exon 51
(p.V1627I)
Valine → isoleucine
A CC T A TT GGCC
Negative
control
Patient
Alw NI
Mother260 J.-W. Cho, H. Nakano, and K.-S. Lee
tion in one allele and missense mutation (Val → Ile, 1627)
in the other allele. The mother and father may be carrier state
and remain unaffected clinically. 
DISCUSSION
EB is a group of inherited skin diseases characterized by
blistering and scarring of the skin after mild trauma. DEB
is transmitted in an autosomal dominant or recessive pattern,
both forms showing tissue separation beneath the basement
membrane at the level of the anchoring fibrils (16). Type VII
collagen molecules, major component of anchoring fibrils,
are homotrimers, each pro α 1 (VII) polypeptide chain con-
taining a central triple-helical collagenous domain (145 kDa
in size) flanked by both a large (145 kDa) amino-terminal
noncollagenous (NC-1) domain and a small (30 kDa) car-
boxy-terminal noncollagenaous (NC-2) domain (17). The
NC-1 domain consists of submodules with homology to an
adhesive protein, including a matrix-protein motif, a fibro-
nectin like domain, and a von Willebrand factor A domain
(18). The NC-2 domain contains conserved cysteins involved
in the formation of disulfide linkage between type VII col-
lagen homotrimers (19, 20). In the conversion of procollagen
VII to collagen VII, two procollagen VII molecules form an
anti-parallel dimmer with eight cysteines in the carboxyl-
terminal NC-2 domain, which is finally removed at the pro-
collagen C-proteinase cleavage site. RDEB comprises sever-
al forms, the most severe of which is the Hallopeau-Siemens
type (HS-RDEB). Other forms of RDEB comprise the mitis
(M-RDEB), the inverse, and the localized types. It has been
suggested that the nature and/or the location of mutations
in COL7A1 determine the variations in clinical phenotype
and type VII collagen expression. PTC mutations are silent
when in a heterozygous state, but when homozygous or com-
bined with another PTC mutation in other alleles, the con-
sequences are severe in terms of skin fragility, as illustrated
by HS-RDEB (9-12). In support of this interpretation, a
majority of mutations reported in HS-RDEB result from
PTC, which are thought to lead to null alleles through PTC-
mediated mRNA decay (21). PTC association with either a
glycine substitution, a slice-site mutation, or, a delayed ter-
mination codon have also been characterized in clinically
moderate form of RDEB (12, 22, 23).
It has been known that Hallopeau-Siemens variant RDEB
involves PTC mutations on both COL7A1 alleles leading to
an absence of collagen VII and no detectable anchoring fib-
rils. However, in this study, electron microscopy examination
provided evidence that the synthesis of rudimentary anchor-
ing fibrils was still possible although its amount was consid-
erably reduced. We hypothesized that some anchoring fib-
rils were formed in spite of the PTC mutations on COL7A1
allele, and maybe that is why the skin fragility and scar for-
mation was not so severe in our patient. Actually, our patient
showed a PTC (c.8569G>T) in exon 116. Exon 116 is locat-
ed in the middle of the NC-2 domain, and we hypothesized
that the truncated procollagen VII from the mutant allele
with a PTC in exon 116 included two out of eight cysteines
needed for disulfide bond formation, and hence a few func-
tional anchoring fibrils could be formed. It is possible that
the mutant allele of c.8569G>T may be inherited from father,
due to the mother allele is normal. However, it still remains
to be determined this mutant allele is really inherited from
father. The both patient and mother have another novel muta-
tion that G to A transition at position 4879 within exon 51;
the codon for valine (VAL) is changed to a codon for isoleucine
(Ile), and resulting in the substitution is occurred within the
collagenous domain that form the collagen VII triple helix.
In this study, the mother did not show any signs of mucocu-
taneous and nail involvement despite a careful reexamination.
It still needs to investigate the maternal mutation c.4879G>
A will be interpreted as a silent mutation or altered splicing. 
In summary, in this study, we reported a moderately severe
RDEB patient, who has the compound mutation of c.8569G>
T in exon 116 and c.4879G>A within exon 51. We hope that
this data contribute to the expanding database on COL7A1
mutations in DEB, and accumulating mutational data on
patients with RDEB have been proved useful in providing
more precise clinical information, particularly in defining
diagnosis and in improving genetic counseling.
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